Logo image of BELYS.BR

BELYSSE GROUP NV (BELYS.BR) Stock Fundamental Analysis

Europe - EBR:BELYS - BE0974314461 - Common Stock

0.88 EUR
+0.04 (+4.14%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

3

Overall BELYS gets a fundamental rating of 3 out of 10. We evaluated BELYS against 33 industry peers in the Household Durables industry. Both the profitability and financial health of BELYS have multiple concerns. BELYS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BELYS had negative earnings in the past year.
BELYS had a positive operating cash flow in the past year.
In the past 5 years BELYS reported 4 times negative net income.
Of the past 5 years BELYS 4 years had a positive operating cash flow.
BELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFBELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

With a Return On Assets value of -0.02%, BELYS is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -0.07%, BELYS is doing worse than 63.64% of the companies in the same industry.
BELYS has a Return On Invested Capital of 6.45%. This is comparable to the rest of the industry: BELYS outperforms 57.58% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BELYS is below the industry average of 10.58%.
Industry RankSector Rank
ROA -0.02%
ROE -0.07%
ROIC 6.45%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
BELYS.BR Yearly ROA, ROE, ROICBELYS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

BELYS's Operating Margin of 6.91% is in line compared to the rest of the industry. BELYS outperforms 57.58% of its industry peers.
In the last couple of years the Operating Margin of BELYS has declined.
BELYS has a better Gross Margin (61.34%) than 84.85% of its industry peers.
In the last couple of years the Gross Margin of BELYS has remained more or less at the same level.
Industry RankSector Rank
OM 6.91%
PM (TTM) N/A
GM 61.34%
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
BELYS.BR Yearly Profit, Operating, Gross MarginsBELYS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BELYS is destroying value.
Compared to 1 year ago, BELYS has about the same amount of shares outstanding.
Compared to 1 year ago, BELYS has an improved debt to assets ratio.
BELYS.BR Yearly Shares OutstandingBELYS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
BELYS.BR Yearly Total Debt VS Total AssetsBELYS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.27, we must say that BELYS is in the distress zone and has some risk of bankruptcy.
BELYS has a worse Altman-Z score (0.27) than 87.88% of its industry peers.
BELYS has a debt to FCF ratio of 5.07. This is a neutral value as BELYS would need 5.07 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.07, BELYS is in the better half of the industry, outperforming 69.70% of the companies in the same industry.
A Debt/Equity ratio of 1.80 is on the high side and indicates that BELYS has dependencies on debt financing.
BELYS's Debt to Equity ratio of 1.80 is on the low side compared to the rest of the industry. BELYS is outperformed by 90.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 5.07
Altman-Z 0.27
ROIC/WACC0.59
WACC10.92%
BELYS.BR Yearly LT Debt VS Equity VS FCFBELYS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

BELYS has a Current Ratio of 1.63. This is a normal value and indicates that BELYS is financially healthy and should not expect problems in meeting its short term obligations.
BELYS's Current ratio of 1.63 is in line compared to the rest of the industry. BELYS outperforms 51.52% of its industry peers.
BELYS has a Quick Ratio of 1.63. This is a bad value and indicates that BELYS is not financially healthy enough and could expect problems in meeting its short term obligations.
BELYS has a Quick ratio of 0.90. This is comparable to the rest of the industry: BELYS outperforms 48.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 0.9
BELYS.BR Yearly Current Assets VS Current LiabilitesBELYS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

3. Growth

3.1 Past

BELYS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -100.58%.
Looking at the last year, BELYS shows a decrease in Revenue. The Revenue has decreased by -6.81% in the last year.
BELYS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.43% yearly.
EPS 1Y (TTM)-100.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.76%
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.97%

3.2 Future

The Earnings Per Share is expected to decrease by 0.00% on average over the next years.
BELYS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.36% yearly.
EPS Next Y-75%
EPS Next 2Y-32.3%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue Next Year-3.57%
Revenue Next 2Y-0.54%
Revenue Next 3Y0.36%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BELYS.BR Yearly Revenue VS EstimatesBELYS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
BELYS.BR Yearly EPS VS EstimatesBELYS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Forward Earnings ratio is 7.77, which indicates a rather cheap valuation of BELYS.
Based on the Price/Forward Earnings ratio, BELYS is valued a bit cheaper than 78.79% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BELYS to the average of the S&P500 Index (22.73), we can say BELYS is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 7.77
BELYS.BR Price Earnings VS Forward Price EarningsBELYS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

BELYS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BELYS is cheaper than 84.85% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BELYS is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.02
EV/EBITDA 3.99
BELYS.BR Per share dataBELYS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-32.3%
EPS Next 3Y0%

0

5. Dividend

5.1 Amount

No dividends for BELYS!.
Industry RankSector Rank
Dividend Yield N/A

BELYSSE GROUP NV

EBR:BELYS (9/12/2025, 7:00:00 PM)

0.88

+0.04 (+4.14%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)09-05 2025-09-05
Earnings (Next)10-20 2025-10-20
Inst Owners14.18%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap31.63M
Analysts84.44
Price Target1.63 (85.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-40%
EPS NY rev (3m)-40%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.17%
Revenue NY rev (3m)-2.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.77
P/S 0.12
P/FCF 1.02
P/OCF 0.77
P/B 0.39
P/tB N/A
EV/EBITDA 3.99
EPS(TTM)0
EYN/A
EPS(NY)0.11
Fwd EY12.88%
FCF(TTM)0.86
FCFY98.15%
OCF(TTM)1.14
OCFY129.25%
SpS7.52
BVpS2.28
TBVpS-0.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.02%
ROE -0.07%
ROCE 7.87%
ROIC 6.45%
ROICexc 7.62%
ROICexgc 15.63%
OM 6.91%
PM (TTM) N/A
GM 61.34%
FCFM 11.48%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
ROICexc(3y)9.09%
ROICexc(5y)7.47%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.69%
ROCE(5y)7.3%
ROICexcg growth 3Y21.04%
ROICexcg growth 5YN/A
ROICexc growth 3Y8.96%
ROICexc growth 5YN/A
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
F-Score4
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 5.07
Debt/EBITDA 3.85
Cap/Depr 50.25%
Cap/Sales 3.64%
Interest Coverage 1.3
Cash Conversion 106.91%
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 0.9
Altman-Z 0.27
F-Score4
WACC10.92%
ROIC/WACC0.59
Cap/Depr(3y)58.36%
Cap/Depr(5y)60.35%
Cap/Sales(3y)3.69%
Cap/Sales(5y)3.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.76%
EPS Next Y-75%
EPS Next 2Y-32.3%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.97%
Revenue Next Year-3.57%
Revenue Next 2Y-0.54%
Revenue Next 3Y0.36%
Revenue Next 5YN/A
EBIT growth 1Y-18.87%
EBIT growth 3Y-4.83%
EBIT growth 5YN/A
EBIT Next Year86.36%
EBIT Next 3Y25.99%
EBIT Next 5YN/A
FCF growth 1Y111.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.84%
OCF growth 3YN/A
OCF growth 5YN/A